105 related articles for article (PubMed ID: 18833266)
1. Regenerative medicine: short cut to cell replacement.
Blelloch R
Nature; 2008 Oct; 455(7213):604-5. PubMed ID: 18833266
[No Abstract] [Full Text] [Related]
2. New beta-cells from old acini.
German MS
Nat Biotechnol; 2008 Oct; 26(10):1092-3. PubMed ID: 18846076
[No Abstract] [Full Text] [Related]
3. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.
Zhou Q; Brown J; Kanarek A; Rajagopal J; Melton DA
Nature; 2008 Oct; 455(7213):627-32. PubMed ID: 18754011
[TBL] [Abstract][Full Text] [Related]
4. Cell biology. Biologists change one cell type directly into another.
Holden C
Science; 2008 Aug; 321(5893):1143. PubMed ID: 18755945
[No Abstract] [Full Text] [Related]
5. PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration.
Zhu Y; Liu Q; Zhou Z; Ikeda Y
Stem Cell Res Ther; 2017 Nov; 8(1):240. PubMed ID: 29096722
[TBL] [Abstract][Full Text] [Related]
6. In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes.
Li W; Nakanishi M; Zumsteg A; Shear M; Wright C; Melton DA; Zhou Q
Elife; 2014 Jan; 3():e01846. PubMed ID: 24714494
[TBL] [Abstract][Full Text] [Related]
7. In vivo direct reprogramming of liver cells to insulin producing cells by virus-free overexpression of defined factors.
Yang XF; Ren LW; Yang L; Deng CY; Li FR
Endocr J; 2017 Mar; 64(3):291-302. PubMed ID: 28100871
[TBL] [Abstract][Full Text] [Related]
8. Plasticity of adult human pancreatic duct cells by neurogenin3-mediated reprogramming.
Swales N; Martens GA; Bonné S; Heremans Y; Borup R; Van de Casteele M; Ling Z; Pipeleers D; Ravassard P; Nielsen F; Ferrer J; Heimberg H
PLoS One; 2012; 7(5):e37055. PubMed ID: 22606327
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming of Pancreatic Acinar Cells to Functional Beta Cells by In Vivo Transduction of a Polycistronic Construct Containing Pdx1, Ngn3, MafA in Mice.
Cavelti-Weder C; Zumsteg A; Li W; Zhou Q
Curr Protoc Stem Cell Biol; 2017 Feb; 40():4A.10.1-4A.10.12. PubMed ID: 28152182
[TBL] [Abstract][Full Text] [Related]
10. Generation of functional insulin-producing cells from mouse embryonic stem cells through 804G cell-derived extracellular matrix and protein transduction of transcription factors.
Kaitsuka T; Noguchi H; Shiraki N; Kubo T; Wei FY; Hakim F; Kume S; Tomizawa K
Stem Cells Transl Med; 2014 Jan; 3(1):114-27. PubMed ID: 24292793
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of iPSCs into insulin-producing cells via adenoviral transfection of PDX-1, NeuroD1 and MafA.
Wang L; Huang Y; Guo Q; Fan X; Lu Y; Zhu S; Wang Y; Bo X; Chang X; Zhu M; Wang Z
Diabetes Res Clin Pract; 2014 Jun; 104(3):383-92. PubMed ID: 24794627
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of pancreatic exocrine cells towards a beta (β) cell character using Pdx1, Ngn3 and MafA.
Akinci E; Banga A; Greder LV; Dutton JR; Slack JM
Biochem J; 2012 Mar; 442(3):539-50. PubMed ID: 22150363
[TBL] [Abstract][Full Text] [Related]
13. ATF2 interacts with beta-cell-enriched transcription factors, MafA, Pdx1, and beta2, and activates insulin gene transcription.
Han SI; Yasuda K; Kataoka K
J Biol Chem; 2011 Mar; 286(12):10449-56. PubMed ID: 21278380
[TBL] [Abstract][Full Text] [Related]
14. Cell-Penetrating Peptide as a Means of Directing the Differentiation of Induced-Pluripotent Stem Cells.
Kaitsuka T; Tomizawa K
Int J Mol Sci; 2015 Nov; 16(11):26667-76. PubMed ID: 26561805
[TBL] [Abstract][Full Text] [Related]
15. Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells.
Kaneto H; Matsuoka TA; Katakami N; Matsuhisa M
Curr Med Chem; 2009; 16(24):3144-51. PubMed ID: 19689288
[TBL] [Abstract][Full Text] [Related]
16. Mafa Enables Pdx1 to Effectively Convert Pancreatic Islet Progenitors and Committed Islet α-Cells Into β-Cells In Vivo.
Matsuoka TA; Kawashima S; Miyatsuka T; Sasaki S; Shimo N; Katakami N; Kawamori D; Takebe S; Herrera PL; Kaneto H; Stein R; Shimomura I
Diabetes; 2017 May; 66(5):1293-1300. PubMed ID: 28223284
[TBL] [Abstract][Full Text] [Related]
17. β-Cell-Specific Deletion of HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) Reductase Causes Overt Diabetes due to Reduction of β-Cell Mass and Impaired Insulin Secretion.
Takei S; Nagashima S; Takei A; Yamamuro D; Wakabayashi T; Murakami A; Isoda M; Yamazaki H; Ebihara C; Takahashi M; Ebihara K; Dezaki K; Takayanagi Y; Onaka T; Fujiwara K; Yashiro T; Ishibashi S
Diabetes; 2020 Nov; 69(11):2352-2363. PubMed ID: 32796082
[TBL] [Abstract][Full Text] [Related]
18. Stage specific reprogramming of mouse embryo liver cells to a beta cell-like phenotype.
Yang Y; Akinci E; Dutton JR; Banga A; Slack JM
Mech Dev; 2013; 130(11-12):602-12. PubMed ID: 23994012
[TBL] [Abstract][Full Text] [Related]
19. Targeted Derivation of Organotypic Glucose- and GLP-1-Responsive β Cells Prior to Transplantation into Diabetic Recipients.
Zhu Y; Tonne JM; Liu Q; Schreiber CA; Zhou Z; Rakshit K; Matveyenko AV; Terzic A; Wigle D; Kudva YC; Ikeda Y
Stem Cell Reports; 2019 Aug; 13(2):307-321. PubMed ID: 31378674
[TBL] [Abstract][Full Text] [Related]
20. Sequential introduction and dosage balance of defined transcription factors affect reprogramming efficiency from pancreatic duct cells into insulin-producing cells.
Miyashita K; Miyatsuka T; Matsuoka TA; Sasaki S; Takebe S; Yasuda T; Watada H; Kaneto H; Shimomura I
Biochem Biophys Res Commun; 2014 Feb; 444(4):514-9. PubMed ID: 24472553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]